Development and analytical validation of a 25-gene next generation sequencing panel that includes the BRCA1 and BRCA2 genes to assess hereditary cancer risk

Overview of attention for article published in BMC Cancer, April 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (88th percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

So far, Altmetric has seen 9 X posts from 6 X users, with an upper bound of 12,173 followers.

NGS assay for 25 genes including BRCA1 and BRCA2 by Myriad Genetic Laboratories. Judkins et al. BMC Cancer. 2015. https://t.co/PnUr4Kv4FX

Development and analytical validation of a 25-gene next generation sequencing panel that includes the… https://t.co/b7ml9D0ciY #DNAnano

Development and analytical validation of a 25-gene next generation sequencing panel that includes the… https://t.co/A6QfqHsVVS #DNAnano

Development and validation of a 25-gene NGS panel that includes the BRCA1 & BRCA2 to assess hereditary cancer risk. http://t.co/d1gftZfq97

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 5 additional X posts.